Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Clobetasol 500micrograms/g foam |
| BNF code | 1304000G0AACCCC |
| Virtual Therapeutic Moiety | Clobetasol |
| Date identifier became valid | 2 May 2023 |
| Previous product identifier | 375770003 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products Available |
| Non-availability status date | 2 Nov 2021 |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Clobetasol propionate |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 500.000 |
| Strength value numerator unit | microgram |
| Strength value denominator | 1.000 |
| Strength value denominator unit | gram |
| Ontology Drug Form & Route | |
| Form & Route | foam.cutaneous |
| Dose Form | |
| Formulation | Cutaneous foam |
| Drug Route | |
| Route | Cutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Clarelux 500micrograms/g foam (Pierre Fabre Ltd) | |
| Virtual Medicinal Product Packs | |
| Clobetasol 500micrograms/g foam 100 gram | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.